Activation of podocyte-specific MC5R signaling by melanocortin therapy protects against THSD7A-associated membranous nephropathy

Authors

  • Jing Liu University of Toledo,department of medicine Author
  • Yan Ge Author
  • Lance Dworkin Author
  • Rujun Gong Author

DOI:

https://doi.org/10.46570/utjms-2025-1354

Keywords:

thrombospondin type 1 domain containing 7A, membranous nephropathy, melanocortin 5 receptor, melanocortin therapy

Downloads

Published

2025-06-30

Issue

Section

Dr. Lance D. Dworkin Department of Medicine Research Symposium

How to Cite

1.
Activation of podocyte-specific MC5R signaling by melanocortin therapy protects against THSD7A-associated membranous nephropathy. Translation. 2025;13(S3). doi:10.46570/utjms-2025-1354

Most read articles by the same author(s)